Suppr超能文献

≤65 岁系统性红斑狼疮成人的虚弱与急诊科利用度:医疗补助受益人的行政索赔数据分析。

Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries.

机构信息

Division of Rheumatology, Hospital for Special Surgery, New York City, New York, USA

Medicine, Weill Cornell Medicine, New York City, New York, USA.

出版信息

Lupus Sci Med. 2023 Jul;10(2). doi: 10.1136/lupus-2023-000905.

Abstract

OBJECTIVE

Frailty is a risk factor for adverse health in adults with SLE, including those <65 years. Emergency department (ED) utilisation is high in adults with SLE, but to our knowledge, whether frailty is associated with ED use is unknown. In a large administrative claims dataset, we assessed risk of ED utilisation among frail adults with SLE ≤65 years of age relative to non-frail adults ≤65 years of age with SLE.

METHODS

Using the MarketScan Medicaid subset from 2011 to 2015, we identified beneficiaries 18-65 years with SLE (≥3 SLE International Classification of Diseases, Ninth Revision codes ≥30 days apart). Comparators without a systemic rheumatic disease (SRD) were matched 4:1 on age and gender. Frailty status in 2011 was determined using two claims-based frailty indices (CFIs). We compared risk of recurrent ED utilisation among frail and non-frail beneficiaries with SLE using an extension of the Cox proportional hazard model for recurrent events data.

RESULTS

Of 2262 beneficiaries with SLE and 9048 non-SRD comparators, 28.8% and 11.6% were frail, respectively, according to both CFIs. Compared with non-frail beneficiaries with SLE, frail beneficiaries with SLE had significantly higher hazard of recurrent ED use (HR 1.75, 95% CI 1.48 to 2.08).

CONCLUSION

Frailty increased hazard of recurrent ED visits in frail adults ≤65 years of age with SLE relative to comparable non-frail adults with SLE. Frailty is a potential target for efforts to improve quality of care in SLE.

摘要

目的

衰弱是 SLE 成人(包括 <65 岁)不良健康的一个风险因素。SLE 成人的急诊科(ED)利用率较高,但据我们所知,衰弱是否与 ED 使用相关尚不清楚。在一项大型行政索赔数据集中,我们评估了≤65 岁衰弱的 SLE 成人相对于≤65 岁非衰弱 SLE 成人的 ED 使用率风险。

方法

使用 2011 年至 2015 年 MarketScan Medicaid 子集,我们确定了年龄在 18-65 岁之间且患有 SLE(≥3 个 SLE 国际疾病分类,第九版代码,间隔 ≥30 天)的受益人群。无系统性风湿性疾病(SRD)的对照者按年龄和性别 4:1 匹配。2011 年衰弱状态采用两种基于索赔的衰弱指数(CFIs)确定。我们使用复发性事件数据的 Cox 比例风险模型的扩展来比较患有 SLE 的衰弱和非衰弱受益人群的 ED 再利用风险。

结果

在 2262 名患有 SLE 的受益人和 9048 名非-SRD 对照者中,根据两个 CFIs,分别有 28.8%和 11.6%的人衰弱。与非衰弱的 SLE 受益人群相比,衰弱的 SLE 受益人群的 ED 再利用复发性风险显著更高(HR 1.75,95%CI 1.48 至 2.08)。

结论

衰弱增加了≤65 岁患有 SLE 的衰弱成年人群相对于可比的非衰弱 SLE 成年人群 ED 再就诊的风险。衰弱是提高 SLE 护理质量的潜在目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5254/10391790/039fa8c94d66/lupus-2023-000905f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验